Market Closed -
OTC Markets
12:02:10 2024-05-13 pm EDT
|
5-day change
|
1st Jan Change
|
5
USD
|
-.--%
|
|
-.--%
|
+11.11%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
0.5928
|
1.186
|
0.5928
|
0.0618
|
1,000
|
1,598
|
Enterprise Value (EV)
1 |
0.5928
|
1.186
|
0.5928
|
0.0654
|
1,000
|
1,598
|
P/E ratio
|
-17.8
x
|
-86.4
x
|
-34.2
x
|
-2.21
x
|
-76,923
x
|
-67,143
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-9.91
x
|
-16.1
x
|
-6.52
x
|
-0.56
x
|
-9,579
x
|
-12,465
x
|
Nbr of stocks (in thousands)
|
29.6
|
29.6
|
29.6
|
30.9
|
200,031
|
200,031
|
Reference price
2 |
20.00
|
40.00
|
20.00
|
2.000
|
5.000
|
7.990
|
Announcement Date
|
10/9/18
|
7/10/20
|
7/14/20
|
10/21/21
|
10/14/22
|
10/13/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.0333
|
-0.0137
|
-0.0173
|
-0.028
|
-0.0129
|
-0.0236
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.0333
|
-0.0137
|
-0.0173
|
-0.028
|
-0.0131
|
-0.0239
|
Net income
1 |
-0.0333
|
-0.0137
|
-0.0173
|
-0.028
|
-0.0131
|
-0.0239
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-1.123
|
-0.4628
|
-0.5848
|
-0.9057
|
-0.000065
|
-0.000119
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/9/18
|
7/10/20
|
7/14/20
|
10/21/21
|
10/14/22
|
10/13/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
|
-
|
-
|
-
|
0
|
0
|
0
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
77.1%
|
20.6%
|
21.1%
|
27.7%
|
12.2%
|
20.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-2.020
|
-2.480
|
-3.070
|
-3.600
|
-0
|
-0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/9/18
|
7/10/20
|
7/14/20
|
10/21/21
|
10/14/22
|
10/13/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.11% | 1B | | +48.39% | 765B | | -6.13% | 354B | | +20.61% | 331B | | +10.00% | 299B | | +18.87% | 248B | | -1.96% | 219B | | +11.11% | 216B | | +5.80% | 164B | | -2.50% | 162B |
Other Pharmaceuticals
|